NPPA issued a notification regarding the fixation of the retail price of Cefuroxime Axetil IP eq. to Cefuroxime 500 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg, for M/s Alps Communication Pvt. Ltd. (Manufacturer) & M/s Jagsonpal Pharmaceuticals Ltd. (Marketer)

Feb 21, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 19, 2026, issued a notification regarding the fixation of the retail price of Cefuroxime Axetil IP eq. to Cefuroxime 500 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg for M/s Alps Communication Pvt. Ltd. (Manufacturer) & M/s Jagsonpal Pharmaceuticals Ltd. (Marketer).

The following has been stated: -

•The Retail Price for Each film-coated tablet containing Cefuroxime Axetil IP eq. to Cefuroxime 500 mg + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg for M/s Alps Communication Pvt. Ltd. (Manufacturer) & M/s Jagsonpal Pharmaceuticals Ltd. (Marketer) is 63.94 (Rs)


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT